title: CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.
abstract: Legionella pneumophila infection of mice induces proinflammatory cytokines and Th1 immunity as well as rapid increases in serum levels of IL-12 and IFNgamma and splenic IL-12Rbeta2 expression. Delta-9-tetrahydrocannabinol (THC) treatment prior to infection causes a shift from Th1 to Th2 immunity and here we demonstrate that CB(1) and CB(2) cannabinoid receptors mediate different aspects of the shift. Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the THC-induced attenuation of serum IL-12 and IFNgamma. IFNgamma production is dependent upon signaling through IL-12Rbeta2 (beta2) and THC treatment suppressed splenic beta2 message; moreover, this effect was CB(1) but not CB(2)-dependent from studies with receptor antagonists and CB1(-/-) and CB2(-/-) mice. Furthermore, observed increases in IL-4 induced by THC, were not involved in the drug effect on beta2 from studies with IL-4 deficient mice. The GATA-3 transcription factor is necessary for IL-4 production and is selectively expressed in Th2 cells. GATA-3 message levels were elevated in spleens of THC-treated and L. pneumophila-infected mice and the effect was shown to be CB(2) but not CB(1)-dependent. Furthermore, GATA-3 regulatory factors were modulated in that Notch ligand Delta4 mRNA was decreased and Jagged1 increased by THC also in a CB2-dependent manner and splenic NFkappaB p65 was increased. Together, these results indicate that CB(1) and CB(2) mediate the THC-induced shift in T helper activity in L. pneumophila-infected mice, with CB(1) involved in suppressing IL-12Rbeta2 and CB(2) involved in enhancing GATA-3.
authors.affiliation: Department of Molecular Medicine, University of South Florida, Tampa, FL 33612, USA. cnewton@health.usf.edu
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Newton
authors.forename: Ping-Jen
authors.initials: PJ
authors.lastname: Chou
authors.forename: Izabella
authors.initials: I
authors.lastname: Perkins
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Klein
mesh_terms: D000818:Animals; D002135:Calcium-Binding Proteins / Q000096:biosynthesis / Q000235:genetics; D003713:Dendritic Cells / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D050990:GATA3 Transcription Factor / Q000096:biosynthesis / Q000235:genetics; D006213:Hallucinogens / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects*; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis / Q000235:genetics; D053712:Interleukin-12 Receptor beta 2 Subunit / Q000096:biosynthesis; D000072100:Jagged-1 Protein; D007877:Legionnaires' Disease / Q000276:immunology*; D008262:Macrophage Activation / Q000187:drug effects*; D008565:Membrane Proteins / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D043884:Receptor, Cannabinoid, CB1 / Q000187:drug effects* / Q000235:genetics; D043885:Receptor, Cannabinoid, CB2 / Q000187:drug effects* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000072099:Serrate-Jagged Proteins; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects*; D018418:Th2 Cells / Q000187:drug effects; D051996:Transcription Factor RelA / Q000096:biosynthesis / Q000235:genetics
chemical_list: D002135:Calcium-Binding Proteins; D050990:GATA3 Transcription Factor; C494748:Gata3 protein, mouse; D006213:Hallucinogens; D036341:Intercellular Signaling Peptides and Proteins; D053712:Interleukin-12 Receptor beta 2 Subunit; C000606274:Jag1 protein, mouse; D000072100:Jagged-1 Protein; D008565:Membrane Proteins; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D000072099:Serrate-Jagged Proteins; D051996:Transcription Factor RelA; D013759:Dronabinol
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5780-5
references.pmid: 10318961
references.citation: J Neuroimmunol. 2000 Oct 2;110(1-2):161-7
references.pmid: 11024546
references.citation: Eur J Pharmacol. 2001 Jul 6;423(2-3):235-41
references.pmid: 11448490
references.citation: J Neuroimmune Pharmacol. 2006 Mar;1(1):50-64
references.pmid: 18040791
references.citation: Eur J Pharmacol. 2008 Mar 17;582(1-3):145-53
references.pmid: 18242599
references.citation: Eur J Pharmacol. 2000 May 19;396(2-3):141-9
references.pmid: 10822068
references.citation: J Immunol. 2001 Jun 15;166(12):7276-81
references.pmid: 11390477
references.citation: Infect Immun. 2000 Sep;68(9):5234-40
references.pmid: 10948149
references.citation: Eur J Biochem. 2002 Aug;269(15):3771-8
references.pmid: 12153574
references.citation: Curr Opin Hematol. 2008 Jan;15(1):59-63
references.pmid: 18043247
references.citation: J Pharmacol Exp Ther. 1993 Nov;267(2):635-40
references.pmid: 7504099
references.citation: J Immunol. 2007 Sep 15;179(6):3452-62
references.pmid: 17785779
references.citation: Nat Med. 2007 Apr;13(4):492-7
references.pmid: 17401376
references.citation: Infect Immun. 2002 Jul;70(7):3311-7
references.pmid: 12065467
references.citation: Immunity. 1998 Nov;9(5):745-55
references.pmid: 9846495
references.citation: J Immunol. 2000 Jul 1;165(1):373-80
references.pmid: 10861074
references.citation: Immunogenetics. 2006 Sep;58(9):714-25
references.pmid: 16924491
references.citation: J Exp Med. 2000 Jul 3;192(1):105-15
references.pmid: 10880531
references.citation: J Leukoc Biol. 2007 Jan;81(1):336-43
references.pmid: 17041005
references.citation: J Pharmacol Exp Ther. 2006 Oct;319(1):269-76
references.pmid: 16837556
references.citation: Pharmacol Ther. 1997;74(2):129-80
references.pmid: 9336020
references.citation: Trends Pharmacol Sci. 2006 Jan;27(1):1-4
references.pmid: 16318877
references.citation: J Pharmacol Exp Ther. 1996 Feb;276(2):776-83
references.pmid: 8632350
references.citation: J Allergy Clin Immunol. 2008 Apr;121(4):1000-5.e8
references.pmid: 18313135
references.citation: J Biol Chem. 2006 Jul 21;281(29):20577-88
references.pmid: 16687412
references.citation: Immunol Rev. 2004 Dec;202:203-22
references.pmid: 15546395
references.citation: Annu Rev Immunol. 2007;25:821-52
references.pmid: 17201677
references.citation: Immunol Res. 2003;28(1):25-37
references.pmid: 12947222
references.citation: Nat Immunol. 2001 Jan;2(1):45-50
references.pmid: 11135577
references.citation: Science. 2007 Jun 8;316(5830):1494-7
references.pmid: 17556587
references.citation: Immunity. 2007 Jul;27(1):100-10
references.pmid: 17658278
references.citation: Immunity. 2003 Dec;19(6):781-91
references.pmid: 14670296
references.citation: Immunology. 2006 Feb;117(2):271-9
references.pmid: 16423063
references.citation: J Leukoc Biol. 2004 Oct;76(4):854-61
references.pmid: 15258190
references.citation: Nat Rev Immunol. 2005 May;5(5):400-11
references.pmid: 15864274
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2699-704
references.pmid: 18263732
references.citation: Eur J Pharmacol. 2006 Feb 17;532(1-2):170-7
references.pmid: 16443217
references.citation: Cell. 1997 May 16;89(4):587-96
references.pmid: 9160750
references.citation: Infect Immun. 2003 Nov;71(11):6672-5
references.pmid: 14573695
references.citation: J Leukoc Biol. 2008 Mar;83(3):785-96
references.pmid: 18073275
references.citation: DNA Cell Biol. 1997 Mar;16(3):301-9
references.pmid: 9115639
references.citation: J Immunol. 2000 Dec 1;165(11):6221-8
references.pmid: 11086056
references.citation: Nat Immunol. 2002 Jul;3(7):643-51
references.pmid: 12055628
references.citation: Pharmacol Rev. 2002 Jun;54(2):161-202
references.pmid: 12037135
references.citation: Infect Immun. 1988 May;56(5):1187-93
references.pmid: 3128479
references.citation: Microbes Infect. 2001 Feb;3(2):99-107
references.pmid: 11251296
references.citation: DNA Cell Biol. 2004 Jun;23(6):341-50
references.pmid: 15231067
references.citation: Annu Rev Immunol. 1989;7:145-73
references.pmid: 2523712
references.citation: Infect Immun. 1994 Sep;62(9):4015-20
references.pmid: 8063421
references.citation: J Immunol. 2008 Jan 15;180(2):1050-9
references.pmid: 18178845
references.citation: J Immunol. 2000 Jun 15;164(12):6461-6
references.pmid: 10843702
references.citation: Cell. 2000 Mar 17;100(6):655-69
references.pmid: 10761931
references.citation: Adv Exp Med Biol. 2007;601:395-413
references.pmid: 17713029
references.citation: Infect Immun. 2001 Mar;69(3):1929-33
references.pmid: 11179377
references.citation: Nat Immunol. 2000 Sep;1(3):199-205
references.pmid: 10973276
references.citation: Immunity. 2000 Jan;12(1):27-37
references.pmid: 10661403
references.citation: Immunology. 2008 Mar;123(3):326-38
references.pmid: 17983439
references.citation: Cell. 2004 May 14;117(4):515-26
references.pmid: 15137944